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AbstrAct:  Anticoagulant compounds are likely to play an important role in the control of commensal rodents for crop protection 
and conservation for the foreseeable future.  However, there are concerns regarding their persistence and the development of more 
widespread resistance.  We are seeking to retrieve and retain older alternatives as well as developing novel rodenticides.  Our three-
pronged approach is, firstly, to improve the performance of older non-anticoagulant rodenticides, such as sodium fluoroacetate (1080) 
and zinc phosphide; secondly to optimise the performance of 1st-generation anticoagulants; and thirdly, to identify alternatives to 
anticoagulant rodenticides with the same mode of action as para-aminopropiophenone (PAPP), which was registered in New Zealand 
as a predacide in April 2011.  Zinc phosphide was also registered in New Zealand for the first time in 2011, and combinations of 
ultra-low-dose cholecalciferol with first generation anticoagulants are being advanced to provide the performance characteristics of a 
2nd-generation anticoagulant with a lower risk of bioaccumulation and secondary poisoning. 
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INTRODUCTION
The most prolific period of rodenticide development 
occurred between the 1940s and the 1980s.  First-
generation anticoagulant rodenticides and zinc phosphide 
were developed in the 1940s, 1950s, and 1960s.  Then 
came cholecalciferol, bromethalin, and 2nd-generation 
anticoagulant rodenticides in the 1970s and 1980s, partly 
to overcome resistance to the less potent anticoagulants 
(Buckle and Smith 1994).  During this period it was 
recognised that it was important to have 2 classes of 
rodenticides, both anticoagulants and alternatives to 
anticoagulants.  In recent times, the need for effective 
toxicants for field use that are less persistent than 2nd-
generation anticoagulants, and therefore likely to be less 
hazardous to non-target birds and other non-target species, 
has been highlighted.  Ironically, registration requirements 
in the U.S., Europe, and around the world have reduced 
the number of options available for rodent management. 
We believe it is important to retain and refine the use of 
rodent control tools for conservation, disease control, 
and agricultural protection, and develop new alternatives 
to anticoagulants.  Ideally, alternatives to existing anti-
coagulants would combine limited persistence and 
humaneness; however, this is a significant challenge.  
Considerable effort has been put into the retention of 
sodium fluoroacetate (1080) to support conservation goals 
and an effective tuberculosis vector eradication strategy 
(Eason et al. 2011).  In addition, a microencapsulated 
form of zinc phosphide has been developed, and a low 
dose of cholecalciferol combined with diphacinone or 
coumatetralyl is being re-evaluated (Eason et al. 2010a) to 
provide 3 low residue alternatives. 
In April 2011, para-aminopropiophenone (PAPP), a 
methaemoglobinaemia inducer, was registered for the 
control of predators in New Zealand.  PAPP is humane in 
its mode of action and does not bioaccumulate.  It has an 
antidote and is highly toxic to species like stoats (Mustela 
erminea) (Eason et al. 2010b) but unfortunately not toxic 
to rodents.  Approximately 50 compounds with the same 
mode of action, including analogues of PAPP, have recently 
been screened to assess their potency as rodenticides.
METHODS
To test an active ingredient not previously registered 
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in New Zealand, groups of caged rats were presented with 
a microencapsulated form of zinc phosphide containing 
1.5% a.i. in a palatable paste bait.  Coumatetralyl (0.03%) 
combined with cholecalciferol (0.015%), and diphacinone 
(0.05%) also combined with cholecalciferol (0.015% and 
0.03%), were tested on caged rats in the same bait matrix. 
Analogues of PAPP were screened for their potency as 
rodenticides.  In vitro work was carried out using a meth-
aemoglobin assay involving hepatic microsomes and rat 
erythrocytes.  The toxicity of the most promising candi-
dates from the in vitro screening were recently assessed in 
vivo in laboratory rats by oral gavage.
RESULTS
 A micro encapsulated  form of zinc phosphide contain-
ing 1.5% a.i. has been shown to be 100% effective in caged 
rats.  In addition, further toxins are being researched.  A 
combination of coumatetralyl (0.03%) and cholecalciferol 
(0.015%) has also been confirmed as having high potency 
in rats, similar to that achieved by diphacinone (0.05%) 
and cholecalciferol (0.15%).  Diphacinone (0.05%) was 
partially effective as a single-dose rodenticide when com-
bined with cholecalciferol (0.015%), and was more effec-
tive when combined with a higher dose of cholecalciferol 
(0.03%).  Both PAPP and sodium nitrite have been devel-
oped as vertebrate pesticides in New Zealand and Australia 
(Eason et al. 2010b).  In laboratory rats, neither compound 
is sufficiently potent to be an effective rodenticide.  Ap-
proximately 50 compounds with the same mode of action, 
including analogues of PAPP, have been screened for their 
potency as rodenticides.  This screening has identified a 
compound with an LD
50
 of approximately 40-50 mg/kg. 
Further derivatives of this more potent analogue are being 
synthesized and screened. 
CONCLUSIONS
It has been suggested that product innovation needs to 
be stimulated to encourage alternatives to the current suite 
of rodenticides, as a number of these are associated with 
secondary poisoning, bioaccumulation, or are viewed as 
inhumane (Mason and Littin 2003).  We have advanced 
an improved formulation of zinc phosphide and are con-
firming the synergistic effects of cholecalciferol when 
co-administered with 1st-generation anticoagulants.  Zinc 
phosphide was registered for possum (Trichosurus vul-
pecula) control in 2011 and this registration will be ex-
tended to cover rodents in 2012. 
These developments may provide partial solutions 
and help provide products that break the cycle of roden-
ticide resistance (which can develop with overuse of an-
ticoagulants); however, they are not an advance in term 
of reducing welfare impacts.  To produce completely new 
rodenticides, a new approach is needed.  Our current ap-
proach is to attempt to build on the platform created by 
PAPP.  We are part-way through a programme of research, 
development, and registration activity, and further in vi-
tro and in vivo testing is scheduled over the next 3 years 
on novel candidates, as well as progression to field trials 
for those showing promise.  Any new tools which emerge 
would most likely need to be integrated with anticoagu-
lant rodenticides, which are likely to play an important 
role in the control of rodents for the foreseeable future. 
Importantly, 1080 has been retained in New Zealand for        
possum control and is also used as a rodenticide in some 
settings, such as multispecies possum and rodent control 
programmes.
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